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Abstract 
2-(Di-2-pyridylamino)pyrimidine (L), a potentially ditopic tetradentate ligand, was synthesized 
from commercially available di-2-pyridylamine and 2-chloropyrimidine.  Despite being capable of 
bridging two metal atoms with bidentate chelation of both metal centres, L prefers to chelate or 
bridge through the more basic pyridyl donors of the di-2-pyridylamine moiety.  Mononuclear trans-
[Fe(NCS)2(L)2] and [Cu(L)2(H2O)](BF4)2·H2O complexes, and a discrete [Ag2(L)4](PF6)2 metallo-
macrocycle were isolated and structurally characterized by X-ray crystallography.  A mononuclear 
palladium complex [PdCl2(L)]·(solvate), where solvate = ½H2O or CH2Cl2, was also readily 
obtained in 71% yield.  One example of the ligand acting as a bis(bidentate) bridging ligand was 
observed in a dinuclear [(PdCl2)2(L)]·¾H2O complex that was obtained only in very low yield (ca. 
3%) from the reaction that produced [PdCl2(L)]·½H2O.  trans-[Fe(NCS)2(L)2] undergoes a 
temperature dependent HS-LS (HS = high spin; LS = low spin) crossover at ca. 205 K that was 
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observed by X-ray crystallography and magnetic measurements and attempts were made to 
understand the structural basis of this process.  Despite efforts to isolate examples of L bridging two 
iron(II) centres, only the mononuclear trans-[Fe(NCS)2(L)2] species could be obtained. 
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Introduction 
The magnetic properties of multinuclear transition metal complexes have received sustained 
attention due to interest in their fundamental spin-crossover (SCO) properties and potential 
applications as switches, for memory storage, and as sensors, for example.[1-8]  In this regard, 
multinuclear transition metal complexes in which the bridging ligands have the potential to chelate 
all metal centres engenders materials with greater stability, potentially enhanced metal–metal 
interaction, and improved magnetic switching behaviour.[3, 5, 7]  Improved cooperativity in switching 
can result in improved hysteretic behaviour and, from a device perspective, a more useful SCO 
system.[3, 5, 7]  An example of such a chelating ligand, 2,2’-bipyrimidine (bpym), has been the 
subject of significant investigation and has been shown to form complexes with short metal–metal 
distances.[9]  For example, Real’s classic Fe(II) dinuclear SCO complexes,[10, 11] 
[{Fe(bpym)(NCE)2}2-μ-bpym] (E = S, Se) utilize bpym to facilitate spin coupling in this SCO 
system with short metal–metal separations of ∼5.5 Å. 
 
Bridging ligands possessing 2,2’-bipyridine (bpy) and 1,10-phenanthroline units (phen),[12] di-2-
pyridylmethane (dpm),[13, 14] and di-2-pyridylamine (dpa)[13] chelating motifs, Figure 1(a), for 
facilitating strong metal–metal interactions within multinuclear complexes have been studied.  In 
the context of systems for spin crossover, the use of di-2-pyridylamine as a chelating motif has 
attracted considerable attention.[15-22]  Kepert and Murray observed either a one-step or a two-step 
full spin crossover for dinuclear iron(II) complexes of 2,5-bis(di-2-pyridylamino)pyridine (1), with 
spin states HS–HS, HS–LS and LS–LS (HS: high spin, LS: low spin) for the two iron(II) centres at 
the three plateau temperatures in the two-step case.[15, 16]  The incorporation of pyrimidine as a core 
in such ligands in the form of 4,6-bis(di-2-pyridylamino)pyrimidine (2) and its application in a SCO 
system has been reported,[17, 18].  Triazine derivatives have also been much studied in respect of 
SCO chemistry;[23, 24] some work on compounds containing two di-2-pyridylamine arms has been 
reported (3),[19] as has work on the tritopic version (4).[20-22]   
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Figure 1. (a) Commonly encountered heterocyclic chelating moieties used in bridging ligands. (b) 
The structures of 2,5-bis(di-2-pyridylamino)pyridine (1), 4,6-bis(di-2-pyridylamino)pyrimidine (2), 
2-chloro[4,6-(di-2-pyridylamino)]-1,3,5-triazine (3), 2,4,6-tris(di-2-pyridylamino)-1,3,5-triazine (4) 
and 2-(di-2-pyridylamino)pyrimidine (L). 
 
We proposed that one of the simplest bis(bidentate) bridging ligands in this class would be 2-(di-2-
pyridylamino)pyrimidine (L) in which two metal centres would be separated by a pyrimidine ring, 
akin to Real’s 2,2’-bipyrimidine SCO complexes.[10, 11]  Herein, we report the synthesis of L from 
2-chloropyrimidine and di-2-pyridylamine, and the synthesis of mononuclear trans-[Fe(NCS)2(L)2], 
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[Cu(L)2(H2O)](BF4)2·H2O, [PdCl2(L)] ·(solvate), where solvate = ½H2O or CH2Cl2, and dinuclear 
[(PdCl2)2(L)]·¾H2O and [Ag2(L)4](PF6)2 complexes. We also describe the temperature dependent 
HS-LS crossover for trans-[Fe(NCS)2(L)2] by X-ray crystallography and magnetic measurements. 
 
Results & Discussion 
Ligand Synthesis 
The method of Mosny and Crabtree[25] for the synthesis of tri-2-pyridylamine was adapted for the 
synthesis of 2-(di-2-pyridylamino)pyrimidine (L). Thus, reaction of di-2-pyridylamine with 2-
chloropyrimidine in refluxing mesitylene provided low yields of the desired product L (typically 
10-15%).  Due to the greater availability of 2-chloropyrimidine, we tried to improve the yield of L 
by using a reasonable excess of this reagent (four equivalents) as reported;[25] unfortunately, this 
resulted in a mixture of product and residual 2-chloropyrimidine that was extremely difficult to 
purify.  Limited attempts at synthesising L by Buchwald-Hartwig amination chemistry starting from 
2-aminopyrimidine and 2-bromopyridine were unsuccessful despite this generally being a viable 
route to di-2-pyridylamine containing bridging ligands.[13]  Thus, we returned to our original 
reaction conditions, which were exploited to produce sufficient quantities of the L for 
characterization and subsequent investigation of its coordination chemistry. 
 
Synthesis, structures, and properties of trans-[Fe(NCS)2(L)2] 5 
Among the first compounds we attempted to synthesize were dinuclear and polymeric iron(II) 
complexes of L from Fe(ClO4)2·6H2O (Scheme 1).  This was initially attempted by reacting 
Fe(ClO4)2·6H2O and L in a 2:1 or 1:1 ratio in the presence of excess KSCN.  In both cases the main 
product isolated was trans-[Fe(NCS)2(L)2] (5), where L acts as a simple chelating ligand, and not 
the desired dinuclear and polymeric iron(II) complexes.  As reported herein (Scheme 1), complex 5 
could be prepared directly by undertaking the reaction of L with Fe(ClO4)2·6H2O using a slightly 
greater than 2-fold excess of L, which gave yellow-brown crystals in 37% yield.  The IR spectrum 
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confirmed the presence of L, with characteristic bands at 1600, 1558, 1465, and 1402 cm−1 
corresponding to the ligand, while the N-bound thiocyanate anions were established by observation 
of the CN stretch at 2054 cm−1,[17] that is consistent with a high spin complex.  The microanalysis 
data matched the calculated values for trans-[Fe(NCS)2(L)2] 5.  The formulation of the complex 
was further supported by electrospray mass spectrometry (ES-MS) that revealed an ion with m/z = 

























Crystal Structures of trans-[Fe(NCS)2(L)2] 5 at 150 and 293 K 
Mounting crystals of 5 on the diffractometer at 150 K led to a rapid darkening of the yellow crystals 
consistent with a HS-LS SCO.  Thus, data collections on trans-[Fe(NCS)2(L)2] were undertaken at 
room temperature and 150 K.  Variable temperature unit cell determinations were also carried out to 
ascertain the onset of the SCO.  At all temperatures studied, compound 5 crystallises in the triclinic 
space group P-1 with half the molecule (one ligand, one thiocyanate anion and half an iron(II) 
centre) in the asymmetric unit.  The iron atom is located on a centre of inversion.  In the room 
temperature form of the structure (5RT), Figure 2(a), the Fe-N bond lengths are in the range 
2.0981(17) – 2.2277(14) Å.  These are consistent with the high spin form of Fe(II) with six N-donor 
ligands (typical Fe-N bond length ca. 2.1 Å).[1, 26]  In the room temperature form the N-Fe-N angle 
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of the di-2-pyridylamine moiety is more acute (81.99(6) vs 86.52(5) for 5LT), as a consequence 






Figure 2. (a) A view of the low temperature, low-spin form of trans-[Fe(NCS)2(L)2] and (b) the 
packing of this complex, viewed down the b-axis.  Selected bond lengths (Å) and angles (): 5RT, 
Fe1-N21 2.1971(15), Fe1-N31 2.2277(14), Fe1-N40 2.0981(17), N40-Fe1-N21 90.34(6), N40-Fe1-
N31 92.12(6), N21-Fe1-N31 81.99(6); 5LT, Fe1-N21 1.9873(13), Fe1-N31 1.9927(13), Fe1-N40 
1.9503(14), N40-Fe1-N21 91.22(5), N40-Fe1-N31 92.54(5), N21-Fe1-N31 86.52(5). 
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In the low temperature (150 K) form of trans-[Fe(NCS)2(L)2], Figure 2(b), the Fe-N bond lengths 
range from 1.9503(14) to 1.9927(13) Å and, as expected, are considerably (0.14 – 0.23 Å) shorter 
than those observed in the room temperature structure.  Typical Fe-N bond lengths for a LS iron(II) 
complex are ca. 1.95 Å.[1, 26] The most significant contraction in bond lengths occurs for the pyridyl 
donors of L, consistent with the major contraction in the unit cell parameters occurring along the a-
axis.  In HS trans-[Fe(NCS)2(L)2] the a-axis length is 8.63 Å and this contracts to 8.35 Å at 150 K, 
with the onset of the contraction occurring around 205 K.  Aside from the shorter bond lengths, the 
low-spin form is isostructural with the high-spin structure. 
 
Unit cell determinations on 5 were undertaken at multiple temperatures cycling from 280 K to 150 
K and then warming the sample back to 280 K.  We also determined the unit cell at higher 
temperatures but this just revealed additional minor thermally induced expansion of the unit cell 
parameters.  Throughout the entire experiment, which was repeated on several crystals, the structure 
maintained the same unit cell (Figure 3).  The a-axis undergoes a ca. 0.3 Å contraction during the 
SCO, while the c-axis length is slightly lengthened as a consequence of the HS-LS SCO (elongation 
of 0.1 Å).  The b-axis remains essentially constant across the entire temperature range, although 
during the SCO (at ca. 205 K) there is a slight elongation presumably to accommodate the structural 
reorganisation.  The contraction of the a- axis relates to a shortening of the pyridyl-N bonds to the 
iron(II) centre, while the slight elongation of the c-axis is a consequence of the change in the 
conformation of the chelate ring brought about by the shortening of the Fe-N bonds. The unit cell 
volume change, from HS to LS, was 4.7%, typical of such a spin transition.[1, 26] 
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Figure 3. The unit cell lengths for 5 collected at multiple temperatures from 150 – 280 K (-123 – 
7 °C).  This graph shows the results for an individual crystal cooled from 280 K down to 150 K and 
warmed back to 280 K. 
 
Magnetism of trans-[Fe(NCS)2(L)2] 5 
In Figure 4, we see that the χMT values remain constant at 3.5 cm3 mol-1 K between 280 and 205 K, 
a value typical of HS FeII (μeff  = 5.29 μB) and then show an abrupt HS-LS spin transition at T1/2 of 
205 K before leveling off below ~150 K to a LS value of 0.05 cm3 mol-1 K, the latter arising from 
second order Zeeman effects in the 1A1g state. Heating and cooling showed essentially zero thermal 
hysteresis, in agreement with the variable temperature crystallographic data (vide supra). 
Comparisons to some recent examples of bis-dipyridylamino chelates show that the cis derivative 
[Fe(NCS)2(DDE)2, where DDE = N2,N2,N4,N4-tetraethyl-N6,N6-di(pyridin-2-yl)-1,3,5-triazine-2,4,6-
triamine,[23] a ligand with a diethylamino-substituted-triazine ‘tails’, has the same T1/2 value and no 
hysteresis, but the transition is less abrupt, i.e. less cooperativity. A polymorph of trans-
[Fe(NCS)2(DBB)2, where DBB = N2,N2,N4,N4-tetrabenzyl-N6,N6-di(pyridin-2-yl)-1,3,5-triazine-
2,4,6-triamine, now containing dibenzylamino tails, shows a slightly less abrupt, non-hysteretic spin 
transition than does 5, with T1/2 = 170 K, while the other polymorph showed a gradual transition, 
with T1/2 ~ 300 K.[24] 
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Detailed comparisons of packing features (π-stacking, H-bonding, chemical pressure, etc.), as well 
as of Fe(II) coordination spheres, were made for the DDE and DBB compounds to try and elucidate 
reasons for differences in T1/2 and in cooperativity in comparison to 5. This was of limited success 
since most such interactions play a part. In compound 5 the most prominent intermolecular 
interactions are edge-to-face -stacking interactions[27] and weak C-H···S hydrogen bonds 
involving the acidic H4/H6 hydrogen atoms of L and the non-coordinated sulfur atoms of the 
thiocyanate ligands (C-H···S: 5LT, dH-S = 2.86, DCS = 3.57 Å, angleC-H···S = 133.0; 5RT, dH-S = 
2.92, DCS = 3.59 Å, angleC-H···S = 128.0).[28, 29]  Each molecule of 5 makes four such weak 
hydrogen bonds to two different molecules of 5 within the structure, while edge-to-face -stacking 
interactions provide connections to four other molecules.  Fe(II) complexes of DDE and DBB lack 
such acidic hydrogen atoms for forming hydrogen bonds of the type observed here for 5. 
 




















T  / K
 
Figure 4. Plot of χMT vs. T for complex 5. The solid line just joins the points. 
 
 11
Coordination chemistry with Ag(I), Cu(II) and Pd(II) 
As a consequence of being unable to obtain dinuclear or polymeric iron(II) complexes in which L 
acted as a bridging ligand, we set out to form complexes with other metal salts that might 
demonstrate the desired coordination mode and provide structural insight into the problems 
associated with tetradentate coordination of L (Scheme 1).  Reaction of methanol solutions of L and 
AgPF6 gave a colourless solution that yielded block-shaped crystals of [Ag2(L)4](PF6)2 (6) in 79% 
yield by slow evaporation.  The IR spectrum confirmed the presence of L, with characteristic bands 
at 1586, 1561 and 1406 cm−1 corresponding to the ligand, and a very strong band at 834 cm−1 
consistent with the P-F stretch of the hexafluorophosphate anion.  Dissolution of the crystals in 
CD3CN gave a 1H NMR spectrum at room temperature with one chemical environment for L, 
inconsistent with the single crystal structure, where the di-pyridylamine moieties of the four ligands 
are found to either bridge or chelate the silver(I) centres.  This was confirmed by variable 
temperature NMR experiments on 6 (to -30°C) which could not resolve individual signals for the 
bridging and chelating modes of L.  This may be a consequence of an exchange process that is rapid 
on the NMR timescale (at room temperature and -30°C) or due to dissociation of 6 to give a 
mononuclear complex [Ag(L)2]PF6 in solution.  The second proposal is supported by ES-MS for 6, 
dissolved in CH3CN, that revealed molecular ions at m/z 604.8 and 606.9 corresponding to 
[107Ag(L)2]+ and [109Ag(L)2]+, respectively.  The ions [107Ag(L)]+ and [109Ag(L)]+ were also 
observed but there was no evidence for the desired dinuclear [Ag2(L)4]2+ complex.  The 1H NMR 
spectrum of dissolved 6 shows minor coordination induced downfield shifts for the pyridine 
hydrogen atoms (Figure SI 1) consistent with chelation of the silver(I) cation by the di-pyridylamine 
moiety of at least one ligand.  The pyrimidine H4 proton is unaffected by coordination and the 
signal for pyrimidine H3/H5 moves slightly upfield.   
 
X-ray crystallography revealed that 6 is a dimetallo-macrocycle in which the two silver centres 
are bridged by the di-2-pyridylamine moieties of two molecules of L, Figure 5(a).  Compound 6 
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crystallizes in the triclinic space group P-1 with one silver atom, two ligand molecules and a 
disordered hexafluorophosphate in the asymmetric unit.  The silver centre adopts a distorted 
tetrahedral geometry that is coordinated by one ligand molecule in a chelating mode and two others 
in the bridging mode mentioned above.  The bridging of the two silver centres as observed here for 
L has been previously seen for other ligands containing a di-2-pyridylamine moiety.[30, 31]  As a 
consequence, the silver centres are separated by 3.42(1) Å, consistent with the type of coordination 
motif in previous work.[30, 31] The pyrimidine ring of L is not involved in coordination of the silver 
but does form intra- and intermolecular -stacking interactions with the coordinated pyridine rings 








Figure 5.  A perspective view of complex 6 showing the chelating and bridging modes of L; (a) 
an ellipsoid plot at 50% probability level and (b) a space-filling representation of the discrete 
complex.  The disordered hexafluorophosphate anions are not shown.  Selected bond lengths (Å) 
and angles (): Ag1-N71a 2.3149(13), Ag1-N21 2.3207(12), Ag1-N61 2.3747(12), Ag1-N31 
2.4859(13), N71a-Ag1-N21 132.17(4), N71a-Ag1-N61 105.39(4), N21-Ag1-N61 122.05(4), N71a-
Ag1-N31 97.23(4), N21-Ag1-N31 83.72(4), N61-Ag1-N31 96.92(4). Symmetry code -X, -Y, 2-Z. 
 
A copper(II) complex, [Cu(L)2(H2O)](BF4)2·H2O (7), was also obtained in which the copper centre 
was chelated by two molecules of L; in both molecules only the pyridyl donors are involved in 
coordination.  Simply combining of methanol solutions of L and Cu(BF4)2 gave blue crystals of 7 in 
26% yield after a few days; this reaction was conducted with several different starting 
stoichiometries but the major isolated product was always the CuL2 complex.  FTIR spectroscopy 
confirmed the presence of L (stretches 1603, 1562, and 1408 cm-1), water (3445 cm-1) and a B–F 
stretch at 1053 cm-1 established the tetrafluoroborate anion.  In the crystal structure of compound 7, 
the copper(II) centre has a geometry best described as distorted square pyramidal chelated by two 
molecules of L in the basal plane, while a water ligand in the axial position completes the 
coordination sphere.  The  parameter for Cu1 is 0.34.[32]  As noted, the pyrimidine rings of L are 
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not involved in coordinating to the copper atom and instead are involved in an intramolecular -
stacking interaction (Figure 6).  A very similar coordination environment is observed for a 
copper(II) complex of 1,4-bis(6-[di-2-pyridylamino]-4-pyrimidyloxy)benzene whereby the copper 
centre is coordinated by two di-2-pyridylamine chelating moieties and the fifth coordination site 
filled by a solvent molecule; in that case a second copper is also coordinated by the ligand.[33] 
 
 
Figure 6.  A perspective view of complex 7 showing the chelating coordination mode of L (non-
coordinated solvate molecules and the tetrafluoroborate anions are omitted for clarity).  Selected 
bond lengths (Å) and angles (): Cu1-N31A 2.015(3), Cu1-N31B 2.018(3), Cu1-N21B 2.028(3), 
Cu1-N21A 2.040(3), Cu1-O37 2.128(3), N31A-Cu1-N31B 173.35(12), N21B-Cu1-N21A 
152.90(12). 
 
We finally turned to the predictable coordination requirements of palladium(II) chloride in an effort 
to obtain an example of L acting as a bis(bidentate) ligand.  Firstly, 8a was obtained in 71% yield as 
a pale yellow-orange precipitate by reacting a methanol solution of L with a dilute hydrochloric 
acid solution of PdCl2 in a M:L ratio of 2.15:1.  The precipitate was readily identified as a 
mononuclear complex [PdCl2(L)]·½H2O (8a) by a combination of FT-IR spectroscopy, 1H NMR 
spectroscopy, ES-MS and elemental analysis.  The 1H NMR spectrum of 8a shows one set of 
 15
pyridyl resonances, consistent with a mononuclear complex coordinated only by the pyridyl donors.  
In addition, more significant downfield shifts of the resonances of the pyridyl protons were 
observed (see Figure SI 2) confirming the coordination mode.  This was further supported by the 
isolation of [PdCl2(L)]·CH2Cl2 (8b) in 82% yield.  Complex 8b was obtained by layering a 
dichloromethane solution of L with THF and then a toluene solution of [PdCl2(PhCN)2], which 
gave, over a few days, a mixture of yellow rod-shaped crystals and yellow precipitate.  An X-ray 
crystal structure obtained from the yellow rod-shaped crystals confirmed the mononuclear nature of 
the complex 8b, as anticipated from NMR studies of both solvates (see Figure SI 2).  Despite the 
use of an Pd:L ratio of 2.15:1 for both the reactions, the major product (71% and 82% yield, 
respectively) was the mononuclear complex [PdCl2(L)].  Eventually, leaving the aqueous-methanol 
filtrate of the reaction used to produce 8a to slowly evaporate allowed us to identify a minor amount 
(<3% isolated yield) of a dinuclear complex, [(PdCl2)2(2-L)]·¾H2O (9), as yellow crystals.  This 
complex was obtained from a solution containing Pd:L in an approximate 5:1 stoichiometry, 
indicating that a large excess of metal is required to force this ligand to bridge metal ions in the 
desired bis(bidentate) mode. 
 
Further confirmation of the coordination mode in both the mononuclear and dinuclear palladium 
complexes came from X-ray crystallography.  Complex 8b crystallizes in the monoclinic space 
group P21/n with one complete molecule in the asymmetric unit, Figure 7(a).  The palladium has the 
expected square planar geometry with bond lengths typical of this donor set and chelation by the 
pyridyl nitrogen atoms only, as established by solution studies.  Complex 9 also has a square planar 
coordination geometry at both palladium centres, which possess almost identical bond lengths and 
angles to the palladium centre in 8b, Figure 7(b).  [(PdCl2)2(2-L)]·¾H2O crystallizes in the 
monoclinic space group C2/c with a complete molecule in the asymmetric unit.  To accommodate 
the bis(bidentate) chelating motif in 9, the di-2-pyridylamine moiety is twisted by approximately 
50 out of the plane of the pyrimidine ring; by comparison this twist is negligible (ca. 4) in 
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complex 8b.  This twisted conformation allows the two six membered chelate rings to adopt the 






Figure 7.  (a) A perspective view of complex 8b showing the chelating coordination mode of L 
in the mononuclear complex (the dichloromethane solvate molecule has been omitted).  Selected 
bond lengths (Å): Pd1-N21 2.030(3), Pd1-N31 2.039(3), Pd1-Cl3 2.2724(10), Pd1-Cl2 2.2844(9).  
(b) A perspective view of complex 9 showing the bis(bidentate) coordination mode of L in 
[(PdCl2)2(2-L)]·¾H2O (the partially occupied water solvate molecules have been omitted).  
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Selected bond lengths (Å) and angles (): Pd1-N21 2.028(3), Pd1-N11 2.047(3), Pd1-Cl3 




A new heterocyclic ligand, 2-(di-2-pyridylamino)pyrimidine L, was synthesised from commercially 
available starting materials in a single step.  By analogy to related work, this compound was 
proposed to be capable of three main coordination modes; chelating and bridging through the dpa 
moiety only, or a tetradentate bis(bidentate) bridging mode involving all four donors, see Figure 8.  
All three modes were observed in this work.  As is typical for these dpa chelating units, the tertiary 
nitrogen atom is planar and this necessitates significant twisting of L in the one dinuclear complex, 















Figure 8. The coordination modes encountered for L in this study. 
 
In spite of being capable of bridging two metal atoms with bidentate chelation of both metal 
centres, L prefers to chelate or bridge through the more basic di-2-pyridylamine moiety.  
Mononuclear trans-[Fe(NCS)2(L)2] (5) and [Cu(L)2(H2O)](BF4)2·H2O (7) complexes, and a discrete 
[Ag2(L)4](PF6)2 metallomacrocycle (6) were isolated and structurally characterized by X-ray 
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crystallography.  A mononuclear palladium complex [PdCl2(L)] was also readily obtained in 71 and 
82% yield (water, 8a, and dichloromethane solvates, 8b, respectively).  Furthermore, one example 
of the ligand acting as a bis(bidentate) bridging ligand was observed in a dinuclear [(PdCl2)2(L)] 9 
that was obtained in very low yield (ca. 3%).  This preference for the chelating and bridging 
coordination modes involving the dpa moiety only is a consequence of the basicity of the nitrogen 
donors; the pyrimidine nitrogens are considerable weaker bases than the pyridine nitrogens due to 
the electron withdrawing effect of the second ring nitrogen atom (pyridine pKa 5.2 vs pyrimidine 
pKa 1.3). 
 
Complex 5 undergoes a temperature dependent HS-LS crossover at 205 K that was observed by X-
ray crystallography and, as an abrupt non-hysteretic spin transition, by magnetic measurements.  
Variable temperature unit cell determinations undertaken on selected crystals of 5 revealed that the 
HS and LS forms have that same triclinic unit cell and that the a-axis undergoes a ca. 0.3 Å 
contraction as a consequence of the HS-LS transition. Analysis of the single crystal X-ray structures 
of both forms of 5 identified that the contraction of the a-axis relates predominantly to a shortening 
of the pyridyl-N bonds to the iron(II) centre.  Attempts to relate crystal packing interactions to the 
cooperativity between SCO molecules, as indicated by the abrupt spin change, showed weak C-
H···S hydrogen bonds and -stacking interactions were the dominant intermolecular forces 
involved in the crystal packing of 5.  We note, with gratitude, that Martin and White paved the way, 
in the 1960’s, for structure-magnetism correlations in mononuclear d-block SCO species.[34]  
Notwithstanding the efforts already made to isolate examples of L bridging two iron(II) centres, we 
are continuing to investigate the synthesis of other Fe(II) complexes of L that may display the 





Melting points were measured on a Gallenkamp melting point apparatus and are uncorrected. 
Elemental analyses were performed by the Campbell Microanalytical Laboratory at the University 
of Otago.  Infrared spectra were collected on a Perkin Elmer 100S Infrared spectrometer in 
Universal ATR mode. NMR spectra were recorded on Gemini 300 MHz NMR spectrometer at 23 
C using a 5 mm probe. 1H NMR spectra recorded in CDCl3 were referenced relative to the internal 
standard Me4Si; 1H NMR spectra recorded in DMSO-d6 were referenced to the solvent peak, 2.6 
ppm.  Electrospray (ES) mass spectra were recorded using a Finnigan LCQ mass spectrometer.  
Unless otherwise stated, all chemicals were obtained from commercial sources and used as 
received.  [PdCl2(PhCN)2][35] was prepared according to the method described in the literature. 
Magnetic susceptibilities were measured on a Quantum Design MPMS XL7 Squid instrument that 
was calibrated against a Pd pellet of accurately known susceptibility value (Quantum Design Inc.). 
The 20 mg sample of 5 was dispersed in a Vaseline mull to prevent any ‘torquing’ of crystallites 
that can occur in the orbitally degenerate HS state. 
 
Synthesis 
Synthesis of 2-(di-2-pyridylamino)pyrimidine (L). Di-2-pyridylamine (2.05 g, 0.0120 mol), 2-
chloropyrimidine (1.65 g, 0.0144 mol), copper powder (0.82 g), potassium iodide (0.47 g), and 
potassium carbonate (4.02 g) were suspended in mesitylene (20 mL).  The mixture was heated at 
160 C for 96 hours, cooled to room temperature and filtered through celite.  The celite pad was 
washed with dichloromethane (3  20 mL) and the organic extracts combined with the mesitylene.  
The solvent was removed by distillation under high vacuum to give an oily solid that was 
recrystallised from ethyl acetate and hexane to give a pale yellow solid (0.35 g, 12%).  Mp 109 – 
110 °C. Anal. found: C, 67.66; H, 4.40; N, 27.84. C14H11N5 requires C, 67.44; H, 4.46; N, 28.10%; 
1H NMR (300 MHz; CDCl3; Me4Si)  = 6.87 (1H, t, 3JHH = 4.8 Hz, pymH4), 7.14 (2H, dd, 3JHH = 
4.9 and 7.4 Hz, pyH5), 7.37 (2H, d, 3JHH = 8.1 Hz, pyH3), 7.74 (2H, dd, 3JHH = 8.1 and 7.4 Hz 
pyH4), 8.46 (2H, d, 3JHH = 4.9 Hz pyH6), 8.48 (2H, d, 3JHH = 4.8 Hz pymH3/H5).  1H NMR (300 
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MHz; CD3CN; Me4Si)  = 6.99 (1H, t, 3JHH = 4.8 Hz, pymH4), 7.16 (2H, dd, 3JHH = 4.9 and 7.4 Hz, 
pyH5), 7.33 (2H, d, 3JHH = 8.1 Hz, pyH3), 7.76 (2H, dd, 3JHH = 8.1 and 7.4 Hz pyH4), 8.32 (2H, d, 
3JHH = 4.9 Hz pyH6), 8.45 (2H, d, 3JHH = 4.8 Hz pymH3/H5).  1H NMR (300 MHz; DMSO-d6; 
Me4Si)  = 7.08 (1H, t, 3JHH = 4.7 Hz, pymH4), 7.19 (2H, dd, 3JHH = 4.9 and 7.4 Hz, pyH5), 7.32 
(2H, d, 3JHH = 8.1 Hz, pyH3), 7.80 (2H, dd, 3JHH = 8.1 and 7.4 Hz pyH4), 8.31 (2H, d, 3JHH = 4.9 Hz 
pyH6), 8.52 (2H, d, 3JHH = 4.7 Hz pymH3/H5).  13C NMR (75.1 MHz; CDCl3; Me4Si)  = 115.61, 
121.07, 121.35, 139.03, 148.11, 155.02, 158.25, 161.37. m/z (ES-MS) 250.1 (MH+), 271.9 (MNa+).  
Selected IR bands (neat, cm−1): 3040 (w), 1584 (s), 1560 (s), 1462 (m), 1401 (s), 1322 (m), 783 (s). 
 
[Fe(NCS)2(L)2] (5). A solution of L (45.1 mg, 0.181 mmol) dissolved in methanol (8 mL) was 
combined with a solution of Fe(ClO4)2·6H2O (22.4 mg, 0.088 mmol) and KSCN (34 mg, excess) in 
methanol (12 mL) to give a purple-red solution.  Over a period of weeks yellow rod-shaped crystals 
of 5 were obtained.  These were collected by decanting the solvent, washing the crystals with two 
portions of cold methanol (2 x 5 mL) and diethyl ether (5 mL), and drying in air (21.6 mg, 37%). 
Mp 282 – 284 °C. Anal. found: C, 53.88; H, 3.20; N, 24.80. C30H22N12S2Fe requires C, 53.73; H, 
3.31; N, 25.07%. Selected IR bands (ATR, cm−1): 2054 (s, CN str.), 1600 (m), 1558 (s), 1465 (s), 
1402 (s), 791 (s). m/z 611.8 ([Fe(NCS)(L)2]+, 100%). λmax/nm: 450 (ε/M−1 cm−1 337) in DMSO. 
 
[Ag2(L)4](PF6)2 (6). A solution of L (25.2 mg. 0.10 mmol) in methanol (2 mL) and a solution of 
AgPF6 (12.5 mg, 0.050 mmol) in methanol (2 mL) were combined and left to slowly evaporate.  
After one week, colourless block shaped crystals were obtained.  These were collected by filtration, 
washed with diethyl ether and dried to give 6 (30.0 mg, 79%). Mp >170°C (dec.). Anal. found: C, 
44.62; H, 2.90; N, 18.88. C56H44N20F12P2Ag2 requires C, 44.84; H, 2.96; N, 18.68%.  Selected IR 
bands (ATR, cm−1): 1586 (m), 1561 (m), 1406 (s), 1330 (w), 834 (vs, P-F str.).  A sample of 6 was 
redissolved in CD3CN: 1H NMR (300 MHz; CD3CN; Me4Si)  = 6.98 (1H, t, pymH4), 7.22 (2H, 
dd, pyH5), 7.40 (2H, d, pyH3), 7.81 (2H, dd, pyH4), 8.34 (2H, d, pyH6), 8.44 (2H, d, pymH3/H5). 
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m/z 356.1 ([107Ag(L)]+, 6%), 358.1 ([109Ag(L)]+, 7%), 560.9, 562.9, 604.8 ([107Ag(L)2]+, 100%), 
606.9 ([109Ag(L)2]+, 92%). 
 
[Cu(L)2(H2O)](BF4)2·H2O (7). A solution of L (24.9 mg. 0.10 mmol) in methanol (3 mL) and a 
solution of Cu(BF4)2·xH2O (11.9 mg, 0.050 mmol) in methanol (2 mL) were combined to give a 
blue-green solution and left to slowly evaporate.  After a few days a blue crystals were obtained.  
These were collected by filtration, washed with methanol, then diethyl ether and dried to give 7 
(10.1 mg, 26%). Mp 298 – 300 °C. Anal. found: C, 43.40; H, 2.99; N, 18.02. C28H26B2N10O2F8Cu 
requires C, 43.57; H, 3.40; N, 18.15%. Selected IR bands (ATR, cm−1): 3445 (w), 3038 (w), 1603 
(m), 1562 (m), 1408 (s), 1053 (s), 1027 (s), 791 (s). m/z 561.0 ([63Cu(L)2]+, 32%), 563.0 
([65Cu(L)2]+, 14%), 579.9 ([63Cu(L)2(H2O)]+, 100%), 581.9 ([65Cu(L)2(H2O)]+, 41%), 595.8, 597.8, 
680.9 ({[63Cu(L)2(CH3OH)](BF4)}+, 100%), 682.9 ({[65Cu(L)2(CH3OH)](BF4)}+, 97%). λmax/nm: 
425 (sh.), 795 (ε/M−1 cm−1 31) in DMSO. 
 
[PdCl2(L)]·(solvent) (solvent = ½H2O, 8(½H2O); solvent = CH2Cl2, 8(CH2Cl2)) and 
[(PdCl2)2(2-L)]·¾H2O (9). Method A: To a solution of L (24.9 mg, 0.100 mmol) dissolved in 
methanol (5 mL) was added a solution of PdCl2 (38.2 mg, 0.215 mmol) dissolved in 2M HCl 
solution (5 mL).  Immediately upon mixing a pale yellow-orange precipitate formed.  This was 
collected by filtration, the solid washed with methanol and diethyl ether, and dried to give 8b (31.0 
mg, 71%).  The orange filtrate was left to slowly evaporate yielding yellow crystals, which were 
collected, washed with methanol and diethyl ether, and dried to give [(PdCl2)2(2-L)] (1.5 mg, 
<3%).  [PdCl2(L)]·½H2O, 8a: Mp >290 °C (dec.). Anal. found: C, 38.62; H, 2.50; N, 15.87. 
C14H12N5O0.5Cl2Pd requires C, 38.60; H, 2.78; N, 16.08%.  1H NMR (300 MHz; DMSO-d6)  = 
7.29 (1H, t, pymH4), 7.69 (2H, dd, pyH5), 8.12 (2H, d, pyH3), 8.29 (2H, dd, pyH4), 8.68 (2H, d, 
pymH3/H5), 8.81 (2H, d, pyH6). Selected IR bands (ATR, cm−1): 1598 (m), 1558 (m), 1481 (m), 
1466 (m), 1402 (vs), 1362 (w), 1331 (w), 1294 (w), 814 (w), 754 (m). m/z 450.5 
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({[PdCl2(L)]+Na}+, 18%), 465.9 ({[PdCl2(L)]+Na(H2O)}+, 5%), 818.9 ({[PdCl2(L)][PdCl(L)]}+, 
100%), 876.5 ({[PdCl2(L)]2+Na}+, 36%), 892.4 ({[PdCl2(L)]+Na(H2O)}+, 25%). λmax/nm: 420 (sh.) 
in DMSO. [(PdCl2)2(2-L)]·¾H2O, 9: Mp >330 °C (dec.). m/z (+ve mode) 532.8 ([Pd2Cl2(L-H)]+, 
57%); (-ve mode) 564.6 ([Pd2Cl3(L-2H)]-, 100%),.  Compound 9 was not obtained in sufficient 
quantities for further analysis. 
Method B: A solution of L (12.6 mg, 0.051 mmol) was dissolved in CH2Cl2 (3 mL), carefully 
layered with THF (3 mL) and then a solution of [PdCl2(PhCN)2] (40.6 mg, 0.106 mmol) dissolved 
in toluene (3 mL).  After several days a mixture of yellow rod-shaped crystals and yellow 
precipitate was obtained.  The combined solid was collected, washed with diethyl ether (5 mL) and 
dried to give 8b (21.3 mg, 82%). [PdCl2(L)]·CH2Cl2, 8b: Mp >290 °C (dec.). Anal. found: C, 37.78; 
H, 2.52; N, 15.54. C14.33H11.67N5Cl2.67Pd requires C, 37.84; H, 2.59; N, 15.40%.  1H NMR (300 
MHz; DMSO-d6)  = 5.85 (1.2H, s, 0.6CH2Cl2), 7.38 (1H, t, pymH4), 7.72 (2H, dd, pyH5), 8.18 
(2H, d, pyH3), 8.35 (2H, dd, pyH4), 8.74 (2H, d, pymH3/H5), 8.87 (2H, d, pyH6). Selected IR 
bands (ATR, cm−1): 3075 (w), 1598 (m), 1559 (m), 1481 (m), 1466 (m), 1402 (vs), 1362 (w), 1331 
(w), 1294 (w), 779 (m), 754 (m). 
 
X-Ray crystallography 
Crystals were mounted under oil on nylon loops.  X-ray diffraction data were collected with Mo-
Kα radiation ( = 0.71073 Å) using a Bruker-AXS Single Crystal Diffraction System fitted with an 
Apex II CCD detector at 110(2) K (structure 6), or an Oxford Diffraction X-calibur single crystal 
X-ray diffractometer at 150(2) K (structures 5LT, 5RT, 8b, 9).  The structure of compound 7 was 
collected with Cu-Kα radiation ( = 1.54184 Å) using an Oxford Diffraction X-calibur Sapphire 3 
single crystal X-ray diffractometer at 150(2) K.  Data sets were corrected for absorption using a 
multi-scan method, and structures were solved by direct methods using SHELXS-97[36] and refined 
by full-matrix least squares on F2 by SHELXL-97,[37] interfaced through the program X-Seed.[38]  In 
general, all non-hydrogen atoms were refined anisotropically and hydrogen atoms were included as 
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invariants at geometrically estimated positions, unless specified otherwise in additional details 
below.  Figures were produced using the program POV-Ray,[39] interfaced through X-Seed.  
Publication materials were prepared using CIFTAB.[40]  Details of data collections and structure 
refinements are given below and in Table 1.  CCDC 860850 - 860855 contain the supplementary 
crystallographic data for these structures.  These data can be obtained free of charge from The 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
Specific details of the structure refinements 
Compound 6: The hexafluorophosphate anion of compound 6 is disordered over two positions with 
an 83:17 ratio of occupancies. 
Compound 9: The hydrogen atoms of the two water molecules lying on special positions in the 
structure of 9 were not located (1½H atoms per asymmetric unit). 
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Table 1. Crystal data and X-ray experimental data for 5–9. 
Compound 5RT 5LT 6 7 8b 9 
Empirical formula C15H11Fe0.5N6S C15H11Fe0.5N6S C28H22AgF6N10P C29H29B2CuF8N10O3 C15H13Cl4N5Pd C14H12.5Cl4N5O0.75Pd2 
Formula weight 335.29 335.29 751.40 802.78 511.50 617.39 
Crystal system triclinic triclinic triclinic monoclinic monoclinic monoclinic 
Space group P-1 P-1 P-1 P21/c P21/n C2/c 
a (Å) 8.6951(5) 8.3568(6) 10.4906(11) 19.0488(15) 10.1517(5) 23.206(2) 
b (Å) 8.7849(5) 8.6842(6) 10.9594(10) 12.1691(6) 13.9219(9) 13.0040(4) 
c (Å) 10.4062(5) 10.4787(7) 13.6662(14) 16.1962(12) 13.3483(8) 18.1675(16) 
 (º) 88.082(4) 87.314(5) 75.933(8) 90 90 90 
 (º) 80.082(4) 80.761(6) 71.510(9) 113.689(9) 89.253(5) 136.070(16) 
 (º) 79.888(5) 78.298(6) 82.371(8) 90 90 90 
Volume (Å3) 770.84(7) 734.92(9) 1442.8(2) 3438.0(4) 1886.37(19) 3803.7(5) 
Z 2 2 2 4 4 8 
Density (calculated) 
(Mg/m3) 
1.445 1.515 1.730 1.551 1.801 2.156 
Absorption coefficient 
(mm-1) 
0.668 0.700 0.833 1.723 1.559 2.466 
F(000) 344 344 752 1632 1008 2380 
Crystal size (mm3) 0.26x0.15x0.04 0.20x0.15x0.05 0.46x0.24x0.23 0.17x0.16x0.13 0.29x0.19x0.04 0.16x0.09x0.04 
Theta range (º) 2.35 – 30.07 2.40 – 29.82 1.61 – 39.49  4.70 – 71.29 2.48 to 26.37 2.53 – 29.21 
Reflections collected 13358 10723 59552 11958 11620 17661 
Observed reflections 
[I>2()] 
4048 3816 15838 6396 3693 4520 
Goodness-of-fit on F2 0.773 0.898 1.187 0.942 1.063 1.060 
R1 [I>2()] 0.0370 0.0340 0.0360 0.0560 0.0327 0.0339 
wR2 (all data) 0.0684 0.0676 0.1191 0.1565 0.0820 0.0775 
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Accessory publications 
1H NMR spectra for complexes 6, 8a, and 8b, and cifs for complexes 5-9 are available from 
the journal’s website. 
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